Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - Aug 2, 2021

Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS application for use with compatible iPhones1, providing a comprehensive digital

What to know about diabetes today

FreeStyle Libre 3: Guide to Cost and Functions - GoodRx

The First National Bank and Trust Company of Newtown Overview

Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review

Abbott's FreeStyle Libre 2 app snags FDA clearance to help users manage diabetes

FreeStyle Libre 2 - US on the App Store

FreeStyle Libre Continuous Glucose Monitoring

2 Million Patients And Beyond: Abbott's FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes

Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes - Apr 27, 2022